Podcasts about healthtech

It has been said that we don't have “big data” in healthcare, but instead a large amount of “small data.”In this episode, Halle speaks with Kyle Armbrester, CEO of Datavant and former CEO of Signify Health (acquired for $8B), about why healthcare data still moves the way it did decades ago and what it will take to modernize it at scale. Kyle reflects on building and leading large health tech companies and explains how fixing data flow could reduce administrative waste, improve security, and make care easier for patients and providers alike.We cover:Why healthcare billing still happens after the fact and how that fuels administrative wasteHow missing data standards led to fax-based workflows and brittle systemsWhy healthcare data is such an attractive target for cyberattacksHow clinical data can be shared digitally without being owned or resoldLeadership lessons from scaling companies through IPOs and acquisitions—About our guest: Kyle Armbrester is Chief Executive Officer of Datavant, a healthcare data platform company with a mission to make the world's health data secure, accessible, and actionable. Datavant operates the largest and most diverse health data exchange in the U.S., connecting more than 70 percent of the 100 largest health systems, all U.S. payers, and 300 plus real world data partners.Previously, Kyle served as CEO of Signify Health, where he led more than 200 percent revenue growth, took the company public in 2021, and guided its acquisition by CVS Health in 2023 for approximately $8 billion. He later served on the CVS Health executive management team, overseeing healthcare delivery strategy and interoperability.Earlier in his career, Kyle was Chief Product Officer and Head of Corporate Development at athenahealth, where he helped scale revenue from $320 million to $1.2 billion and launched the company's partnership marketplace. Kyle has served on multiple healthcare boards and holds an MBA and AB from Harvard University.—Chapters:00:01:20 Introduction to Kyle Armbrester and his journey in healthcare00:03:58 The impact of Athena Health on healthcare innovation00:06:20 Datavant: Revolutionizing health data interoperability00:08:15 The role of Datavant in reducing administrative burden00:12:20 Understanding Datavant's value proposition across stakeholders00:14:00 Consumer products and data accessibility at Datavant00:18:25 The scale and impact of Datavant in healthcare00:19:35 Cybersecurity challenges in healthcare data management00:23:57 Bridging the gap in healthcare regulations00:26:13 Unlocking the value of untapped healthcare data00:29:25 Challenges of value-based care models00:33:23 The reality of being a CEO in healthcare00:37:00 Navigating IPOs vs. Acquisitions00:39:44 Innovating healthcare incentives for better outcomes—Pre-order Halle's new book, Massively Better Healthcare.—

Send us a textAI, GLP-1s, federal policy, and China. Those themes dominated last week's JP Morgan Health Care Conference in San Francisco. But what, if anything are the implications for the broader healthcare world in 2026?Hosts David Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health discuss what stood out most at JPM, including why the GLP-1 wave may be entering a new phase, how Big Tech and AI are reshaping the healthcare landscape, and why China's growing presence in biotech is becoming harder to ignore.

Drs. Rowan and Kessler introduce ozone and PEMF as powerful, natural therapies for improving oxygenation, immune function, and longevity. #OzoneTherapy #PEMF #HolisticHealing

In this episode of Medsider Radio, we sat down with Greg Walters, co-founder & CEO of Excision Medical. Excision is developing a leaflet modification system to enable lifetime management of aortic stenosis.Greg has almost 40 years of experience in cardiovascular devices, holding leadership roles at Kensey Nash Corporation where he led the development of Angio-Seal and several endovascular programs. He later co-founded Essential Medical, which was acquired by Teleflex in 2018, and is an inventor on more than 75 U.S. and European patents.In this interview, Greg discusses why early-stage teams should build to learn rather than to impress, using functional prototypes to generate real feedback and fundraising momentum. He outlines how disciplined safety work — not perfection — defines first-in-human readiness, and what makes a pre-revenue company attractive to strategic acquirers. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Greg Walters.

In this short and sweet solo episode, I'm answering a question I get all the time: “What do you actually do?” As a wellness concierge, my job is to help people map out their healing path, leveraging 20 years of experience, a massive global network of practitioners, and a deep understanding of the body's systems. Whether it's selecting the right red light panel, evaluating whether molecular hydrogen is worth the money, or just getting back to the basics of breath and light, my goal is always clarity, connection, and service.I share why I created the Biological Blueprint program, how I help clients save thousands by skipping the hype, and what makes the Beautifully Broken platform so special. I also walk through the key mechanisms behind PEMF and red light and how they work at the cellular level. This episode is for the curious, the cautious, and anyone looking to make more aligned wellness decisions in 2026. Episode Highlights[00:00] – Redesigning the website for clarity and connection[00:50] – What does a wellness concierge actually do?[02:12] – Why the Biological Blueprint is the foundation of my client work[03:05] – The problem with starting your healing journey with tech[05:30] – Red light therapy: benefits, usage, and what to expect[07:34] – Understanding PEMF: cellular voltage, healing, and blood flow[10:01] – Non-union fractures and the magic of bioelectric signaling[11:10] – The truth about molecular hydrogen: hormesis, not hype[12:00] – How I consult with brands on language, connection, and impact[13:12] – Every episode now has a searchable web page (shoutout to Nicole!)[14:50] – A love letter to the Beautifully Broken team and where we're headed Links & ResourcesThe Biological Blueprint Program: https://www.beautifullybroken.world/biological-blueprintBook a consult or discovery call: https://beautifullybroken.world CONNECT WITH FREDDIEWork with Me: https://www.beautifullybroken.world/biological-blueprintWebsite and Store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/beautifullybroken.world/) YouTube: https://www.youtube.com/@freddiekimmel Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We all want to stay fit and healthy. But how can technology help ? Shiona McCallum discusses new health tech on display at the world's biggest consumer electronics trade show. And if you own cryptocurrency - beware. Thieves could be targeting you. The BBC's Cyber Correspondent, Joe Tidy, joins us to explain more.Presenter: Shiona McCallum Producer: Tom Quinn(Image: A photo of Shiona McCallum wearing an LED face mask. The room is dark and the transparent face mask covers Shiona's face. The light emitting from the mask gives Shiona's face a red glow. Credit: BBC.)

This week, Steve sits down with Ankit Jain, co-founder and CEO of Infinitus Systems, to talk about why voice-based AI has become one of the most rapidly adopted tools in healthcare operations, what's actually working in the field, and where the hype still outpaces reality. Ankit shares six years of lessons from building AI agents that handle 35-minute medical calls end to end, plus his predictions on what 2026 and 2027 will really look like as enterprises attempt to build their own agents.We cover:Why so much of healthcare still runs on phones, faxes, and portalsHow AI agents are handling long, high-stakes medical calls without going off trackWhat large enterprises now expect around security, governance, and zero-hallucination requirementsWhy providers, payers, and pharma are adopting AI for different operational workflowsWhy 2026 may be the year many health systems try to build their own agents, and why most will return to vendors by 2027—About our guest: Ankit Jain is the co-founder and CEO of Infinitus Systems, the agentic healthcare communications platform that automates high-stakes clinical and administrative conversations at scale. Under his leadership, Infinitus supports 44% of the Fortune 50, and many of the largest healthcare organizations in the US. A serial entrepreneur, advisor, and investor, Ankit has built companies and guided innovation at the intersection of technology and AI. He founded Quettra (acquired by Similarweb), helped launch Google Play and the search engine Cuil, and went on to co-found and manage Gradient Ventures, Google's AI-focused venture fund. His background in building distributed systems and safety-constrained AI, combined with hands-on experience scaling products in regulated environments, gives him a pragmatic perspective on how to design trustworthy AI that earns adoption in healthcare. Ankit frequently works with industry leaders on governance, education, and integration strategies that make automation safe, approachable, and scalable.—Chapters:00:01:38 Introduction to Ankit Jain and Infinitus Systems00:02:54 The journey into healthcare entrepreneurship00:03:55 Inspiration behind Infinitus and its mission00:04:55 Evolution of AI in healthcare communications00:08:12 Navigating competition in the AI healthcare space00:10:30 Defensibility and product development insights00:14:00 AI's role in enhancing healthcare accessibility00:15:20 Go-to-Market strategies and lessons learned00:17:52 Deepening engagement in healthcare workflows00:19:33 Competitive dynamics in healthcare AI00:20:42 Addressing industry concerns and challenges00:22:14 The need for industry self-regulation00:23:40 Navigating consumer privacy and AI interactions00:25:27 The future of jobs in healthcare AI00:28:30 The evolution of healthcare AI00:29:37 Lessons for entrepreneurs in healthcare—Pre-order Halle's new book, Massively Better Healthcare.—

Why Education is Your Best Marketing Strategy for 2026 On this episode host Adam Turinas welcomes John Lynn, Founder and Chief Editor of Healthcare IT Today, back to the show to discuss the significant evolution of sponsored content in our industry. On this episode, they explore how the market has shifted away from simple display advertising toward educational storytelling that builds genuine trust with buyers. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Hosts Colin Hung and John Lynn discuss How Will Consumer Health Tech Impact Provider Organizations? To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Send us a textUnsurprisingly, AI dominated the headlines at this year's JPMorgan Healthcare Conference, but there were some other exciting developments that shouldn't be overlooked.CareTalk hosts, David Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, share their on-the-ground insights from JPM, including where AI is delivering substance over hype, why government partnership will play a larger role in health sector reform, and what's driving a renewed sense of optimism across healthcare.

In this episode of Medsider Radio, we sat down with Jaeson Bang, Founder & CEO of Future Cardia. Future Cardia is developing a subcutaneous heart-failure monitoring platform designed to capture both electrical and mechanical cardiac signals through a simple office-based procedure.Jaeson brings more than two decades of experience building implantable cardiac technologies across Medtronic, CVRx, EBR Systems, and Abiomed. Drawing on that background, he questioned industry assumptions around miniaturization and invasive workflows — and built a device that prioritizes performance, durability, and clinical practicality instead.In this interview, Jaeson shares how challenging a core constraint unlocked a faster development path, why deep domain expertise matters more than thrift in regulated markets, and how raising capital outside traditional VC can preserve leverage and buy time.If you'd rather read than listen, here's a link to the full interview with Jaeson Bang.

In dieser Episode spricht Manuel Grossmann, Gründer von Amino Collective, über die Evolution des Healthcare- und Bio-Investments in Europa. Er teilt, warum Europa trotz exzellenter Wissenschaft nur sehr wenige 500M+ Firmen in dem Sektor in der EU gibt, wie AI den größten Impact der nächsten 50 Jahre haben wird und warum themenspezifische Fonds die Zukunft sind. Was du lernst: Investment-Strategie: Thesen-getriebenes Investieren Die Balance zwischen Science & Business Warum Spezialisierung wichtig ist Wissenschaft & Unternehmertum: Die Rolle von Universitäts-Spinouts Wie man wissenschaftliche Teams aufbaut Der richtige Mix aus Skills Venture Capital Evolution: Warum kleine Fonds oft besser sind Die Zukunft des VC-Modells Management Fee vs. Carry Europas Chancen: München vs. Berlin als Hubs Die Transformation des Ökosystems Warum Europa jetzt durchstarten kann ALLES ZU UNICORN BAKERY: https://stan.store/fabiantausch   Mehr zu Manuel: LinkedIn: https://de.linkedin.com/in/manuel-grossmann  Website: https://www.aminocollective.com/  Join our Founder Tactics Newsletter: 2x die Woche bekommst du die Taktiken der besten Gründer der Welt direkt ins Postfach: https://www.tactics.unicornbakery.de/  Kapitel: (00:00:00) Die Vision von Amino Collective (00:15:20) Healthcare & Bio Innovation (00:33:40) Universitäts-Spinouts & Wissenschaftler (00:47:15) Portfolio-Management & Strategien (01:02:00) Venture Capital Evolution (01:10:30) Europas Potenzial (01:24:00) Ausblick & Chancen

Is 2026 the year that changes everything in healthcare?Steve and Halle sit down with legendary healthcare VC Annie Lamont for their annual predictions episode to dive into 2026 predictions and trends that founders and operators should pay attention to. We cover:

Context is Everything On this episode host Adam Turinas dives into the Model Context Protocol (MCP). While it sounds technical, understanding MCP is actually a critical business strategy. It acts as the rules of engagement that allow your AI to access the right data, tools, and brand guidelines safely and effectively. He explain why context architecture is going to matter much more than which specific AI model you use and how getting this right is essential for risk management and accuracy in the healthcare industry. If you want to move beyond generic AI outputs to creating a true competitive advantage, this episode breaks down exactly how to do it. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Send us a textReferrals are meant to connect patients to the care they need, but in reality, they often become a source of delays, dropped handoffs, and administrative chaos. Between intake complexity, missing information, and outdated processes, too many patients get stuck between diagnosis and treatment. Trey Holterman, Co-Founder and CEO of Tennr joins CareTalk host John Driscoll to discuss why referrals break down so often, what makes intake workflows so hard to fix, and how health systems can improve throughput and access without ripping out the systems they already rely on. 

Send us a textModern medicine generates more data than any one clinician or patient can reasonably process, and for people with rare or complex conditions, that gap can mean delayed diagnoses, missed options, and life-altering consequences. As precision medicine advances, the challenge is no longer just having information, but making it understandable and usable when it matters most.Steve Brown, Founder & CEO of CureWise, joins HealthBiz Podcast host David Williams to discuss how AI helped uncover his own missed cancer diagnosis and why patients need better tools to understand their own medical data. 

Jed Ellerbroek previews CES 2026, focusing on robotics and health tech. He also sees defense as a bullish sector, highlighting Boeing (BA) and Transdigm (TDG), the latter being his favorite. While he doesn't think that growth will happen at the same rate as 2025, he expects capex estimates to continue to increase.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Welcome to Pulse: Year in Review, where Louise and George unpack the big stories from Pulse+IT's 2025 Year in Review series.Segment 3: AI and the rise of Virtual CareResources:Pulse+IT 2025 Year in Review: Australian digital health LinkPulse+IT 2025 Year in Review: New Zealand digital health LinkPulse+IT 2025 Year in Review: Allied health breaking new ground LinkPulse+IT 2025 Year in Review: Community and Aged Care LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

We look back on the guidance we've produced in 2025. We're joined by director of medicines evaluation Helen Knight, the deputy director of the centre for guidelines Eric Power, and Anastasia Chalkidou, the programme director of guidance delivery in HealthTech.

Welcome to Pulse: Year in Review, where Louise and George unpack the big stories from Pulse+IT's 2025 Year in Review series.Segment 1: Aged Care's Digital ReckoningSegment 2: Allied Health's Breakthrough YearResources:Pulse+IT 2025 Year in Review: Allied health breaking new ground LinkPulse+IT 2025 Year in Review: Community and Aged Care LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

In this powerful episode of Mindset Mastery Moments, Dr. Alisa sits down with Guy Bar, Founder and CEO of ARGOX, to unpack a journey defined by discipline, innovation, and bold execution.Guy shares how his early experience serving in the Israeli Defense Forces shaped the mindset, resilience, and leadership philosophy that later fueled his transition into entrepreneurship. What began as a solution to a personal training challenge evolved into Hygear Fit and eventually ARGOX—two brands at the forefront of AI-powered fitness and connected health technology.Together, they explore:How military discipline translates into entrepreneurial gritWhy AI-driven fitness is not a trend, but the future of personalized trainingThe real challenges of scaling a hardware and health-tech startup globallyLessons learned from supply chains, product-market fit, and innovation under pressureThe mindset required to build meaningful companies in uncertain environmentsThis episode is a masterclass in vision, adaptability, and execution—especially for founders, innovators, and leaders navigating high-stakes growth while staying anchored in purpose.If you're interested in the intersection of mindset, technology, and the future of human performance, this conversation delivers insight without fluff and strategy without shortcuts.

Welcome to Pulse: Year in Review, where Louise and George unpack the big stories from Pulse+IT's 2025 Year in Review series.Segment 1: AI goes mainstreamSegment 2: Modernisation, Standards, and the Path to IntegrationSegment 3: Risk, Governance & its Relationship to InnovationResources:Pulse+IT 2025 Year in Review: Australian digital health LinkPulse+IT 2025 Year in Review: New Zealand digital health LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Welcome to the latest episode of L.I.F.T.S, your bite‑sized dose of the Latest Industry Fitness Trends and Stories. In this episode, hosts Matthew Januszek and Mohammed Iqbal sit down with Mohit Kumar, Co‑Founder and CEO of Ultrahuman, to explore the explosive rise of smart rings and the future of wearable health technology. Topics covered include: Mohit's unconventional founder journey and early days in metabolic health. Why smart rings are outperforming other wearables in growth. Ultrahuman's approach to sleep, metabolism, and biomarkers. The high‑stakes patent battle with Oura and the U.S. import ban. What resilience really looks like for founders. The future of AI, battery life, and ring‑based health tracking. Why sleep is becoming the most important performance metric.

Healthtech Marketing Predictions for 2026 On this episode host Adam Turinas closes out the year by looking forward. In this episode, you'll hear a range of voices from across healthtech marketing, growth, PR, podcasting, and the Health Launchpad team as they share what's already starting to shift beneath the surface—and what that means for the year ahead. Some of the predictions may feel inevitable. Others might make you a little uncomfortable. That's usually a good sign. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

What happens when a class clown from Monaghan builds one of the most quietly impactful healthtech companies in Europe - and then takes on the U.S. healthcare system? In this year-end episode of The Shot of Digital Health Therapy, we sat down with Neill Dunwoody

Episode 70 - Dr Mark Hudson-Peacock is a Consultant Dermatologist and founder and CEO of Mantara Health Ltd, responsible for launching the first commercially available Pharmacogenomics test in the UK. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

In this episode of Medsider Radio, we sat down Dr. Adam Kadlec, practicing urologist and co-founder of Rivermark Medical.Rivermark is a clinical-stage company developing FloStent, a first-line, reversible device therapy for benign prostatic hyperplasia (BPH).Before launching Rivermark, Adam built a thriving urological practice in Milwaukee and consulted for several device companies — experiences that ultimately revealed how early true device development begins and why physicians rarely get the chance to influence innovation upstream. Partnering with medtech operator Andy Doraiswamy, Adam transitioned from clinician to CEO and is now leading Rivermark through its pivotal trial.In this interview, Adam shares why workflow integration is one of the most overlooked drivers of adoption, how physician-innovators can build the right decision-making infrastructure, and why understanding who actually enrolls patients at clinical sites can make or break a trial. He also touches on the mindset required to stay resilient through the ups and downs of building a medtech startup.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Adam Kadlec.

Join host Dr. Eve Cunningham in conversation with Dr. Shayan Vyas, pediatric intensivist, health-tech leader and Chief Medical Officer at Quadrivia AI, as they unpack the most meaningful shifts in healthcare in 2025 and what those changes signal for the year ahead. From early telemedicine to AI-enabled clinical support, Dr. Vyas has spent more than a decade building technology that actually works for clinicians, making him one of the most experienced physician innovators in the field.Their conversation dives into:How ambient AI finally moved from pilots to enterprise adoptionWhy clinicians' trust in AI is accelerating faster than expectedThe growing imbalance between patient demand and clinical workforce supplyHow technology can reduce friction, extend reach, and improve access to carePredictions for 2026 – from reimbursement instability to the next wave of AI in clinical workflowsPractical advice for clinicians entering digital health, from “falling in love with the problem” to protecting the art of medicineDr. Vyas is not compensated for this podcast.For more information on Cadence, visit https://www.cadence.care/

Fluent Fiction - Mandarin Chinese: Startup Sparks: A Christmas Eve Pitch That Changed Everything Find the full episode transcript, vocabulary words, and more:fluentfiction.com/zh/episode/2025-12-16-23-34-02-zh Story Transcript:Zh: 在一个寒冷的冬日，城市的天空灰蒙蒙的，气温降得很低。En: On a cold winter day, the city's sky was gray and the temperature dropped significantly.Zh: 然而，在这座现代的创业孵化器内，却充满了热情和希望。En: However, inside this modern incubator, there was an atmosphere of enthusiasm and hope.Zh: 圣诞节的装饰让整个房间显得更为温馨，绿意点缀着科技的冷色调。En: The Christmas decorations made the entire room feel cozier, with greenery softening the cool tones of technology.Zh: 梅和陈坐在他们的办公桌旁，眉头紧锁。En: Mei and Chen sat by their desks, their brows furrowed.Zh: 梅是一位聪明而乐观的技术开发者，她对创新充满了热情，但内心深处害怕失败。En: Mei was a smart and optimistic tech developer, passionate about innovation but deeply afraid of failure.Zh: 陈是一个注重策略的思考者，实际而沉稳，但他对他们的创业计划能否成功心存疑虑。En: Chen was a strategic thinker, practical and steady, yet he doubted whether their startup plan would succeed.Zh: 他们的目标很明确：在新年到来之前，获得足够的资金支持，以维持他们的健康科技初创公司的运营。En: Their goal was clear: to secure enough funding before the New Year to maintain the operation of their health tech startup.Zh: 然而，形势不容乐观。En: However, the situation was not optimistic.Zh: 市场竞争激烈，投资者对他们的产品能否大规模推广持怀疑态度。En: The market competition was fierce, and investors were skeptical about the mass adoption of their product.Zh: 此时，节日的临近使得会议和决策的速度放缓，这给他们的计划增加了不小的难度。En: With the holiday season approaching, the speed of meetings and decisions slowed down, adding significant difficulty to their plans.Zh: 梅大胆地提出，要在平安夜亲自向一位潜在的重要投资者展示他们的原型机，用实力说话。En: Mei boldly proposed showcasing their prototype to a potential major investor on Christmas Eve, letting their work speak for itself.Zh: 陈非常支持她的决定，但同时他感到了巨大的压力，担心如果他们失败了，后果将会很严重。En: Chen fully supported her decision but simultaneously felt immense pressure, fearing the serious consequences if they failed.Zh: 到了平安夜，他们站在一排白板前，上面画满了各种图表。En: On Christmas Eve, they stood in front of a row of whiteboards filled with various charts.Zh: 在喧闹的创业孵化器中，梅和陈准备展示他们的心血。En: In the bustling incubator, Mei and Chen were ready to present their hard work.Zh: 初次展示时，他们的原型机忽然出现了问题，这让投资者的兴趣明显减弱。En: During the initial presentation, their prototype suddenly encountered problems, noticeably reducing the investor's interest.Zh: 梅用她出色的解决问题能力，迅速开始现场排查故障。En: Mei, with her excellent problem-solving skills, quickly began troubleshooting the issue on the spot.Zh: 与此同时，陈用充满激情的话语解释他们的愿景和产品的潜在影响力。En: Meanwhile, Chen passionately explained their vision and the potential impact of their product.Zh: 他那真诚和坚定的声音再次激起了投资者的兴趣。En: His sincere and firm voice reawakened the investor's interest.Zh: 经过一番努力，问题终于被解决，原型机顺利运行。En: After much effort, the issue was finally resolved, and the prototype ran smoothly.Zh: 投资者不仅被他们的聪明才智打动，也被他们的毅力与理想所感动。En: The investor was not only impressed by their ingenuity but also moved by their perseverance and ideals.Zh: 最终，投资者决定支持这对充满激情和潜力的创业者。En: In the end, the investor decided to support this passionate and promising pair of entrepreneurs.Zh: 他承诺提供资金，帮助他们实现革命性的健康科技梦想。En: He promised to provide funding to help them realize their revolutionary health tech dreams.Zh: 圣诞节的灯火亮起，喜悦的火花在梅和陈的心中闪烁。En: As the Christmas lights lit up, sparks of joy flickered in Mei and Chen's hearts.Zh: 梅对自己的能力有了更多的信心，而陈也学会了相信他们的共同目标，并相信他们能够克服任何障碍。En: Mei gained more confidence in her abilities, and Chen learned to trust their shared goal and believed they could overcome any obstacle.Zh: 冰雪虽寒，但梦想温暖，他们在这条艰难而美好的路上，坚定地走了下去。En: Though the ice and snow were cold, dreams were warm, and they resolutely continued on this challenging yet beautiful path. Vocabulary Words:incubator: 孵化器enthusiasm: 热情cozy: 温馨furrowed: 紧锁optimistic: 乐观innovation: 创新strategic: 策略的succeed: 成功fierce: 激烈skeptical: 怀疑的adoption: 推广troubleshooting: 排查故障impact: 影响力sincere: 真诚ingenuity: 聪明才智perseverance: 毅力entrepreneurs: 创业者realize: 实现revolutionary: 革命性的overcome: 克服obstacle: 障碍prototype: 原型机firm: 坚定resolve: 解决investor: 投资者charts: 图表operation: 运营doubt: 心存疑虑significantly: 显著pressure: 压力

AI Quick-Take: What's All The Fuss About Gemini? On this episode host Adam Turinas discusses the buzz around Gemini 3, Google's LLM. He digs into Google's big announcement and tries to get past the hype to what it really means for healthtech marketers. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Send us a textFederally Qualified Health Centers (FQHCs) care for more than 30 million Americans, yet many people have never heard of them or understand how they stay afloat. A major piece of their financial survival is the 340B drug pricing program, which has quietly become one of the most important funding mechanisms in the safety net and it is under growing pressure.Scott Seidelmann, CEO of Nuvem, joins CareTalk hosts David E. Williams and John Driscoll to discuss how FQHCs serve underserved communities, why 340B has become essential to their operations, and what policy changes could make or break their ability to deliver care.

In this special HLTH bonus episode of Tech It to the Limit, hosts Sarah Harper and Elliott Wilson battle post-conference fatigue and full-blown health FOMO by bringing the conference floor straight to your earbuds. While Sarah recovers from a “very real case of health FOMO,” Elliott reports from the trenches after surviving days of buzzwords, badge scanners, and $9 lattes. To shake up the usual format, they press play on two standout booth interviews from HLTH.First, Elliott sits down with Dr. Lynne Nowak of Surescripts for a deep dive into seamless prescribing, touchless prior authorization, interoperability, and price transparency. Dr. Lynne breaks down how automation is shrinking prior auth from a multi-day nightmare into a near-instant, 30-second reality, reducing burnout for clinicians and removing friction for patients who just want their meds on time and at a price they can afford.Then, the episode shifts into venture-building mode with returning guest John Beadle of Aegis Ventures. John unpacks how his consortium model is helping health systems move from “innovation theater” to real innovation delivery by building and scaling AI companies faster than the market average. From ambient AI becoming table stakes to the rise of patient-facing agents, he offers a clear view of where healthcare innovation is headed next.In this episode:[00:00] Introduction[01:16] Health conference recap setup[07:13] Interview Dr. lynne Nowak automation and burnout[10:25] Touchless prior authorization explained[12:59] Interoperability and data exchange[18:11] Trust and data governance[19:55] Future of data science at Surescripts[21:12] Interview wrap up Dr. lynne[24:42] Interview John Beadle AI startups and health systems[26:02] Startup success metrics and examples[28:11] Clinician experience and ambient AI[32:19] Advice for health conference attendees[33:07] Sponsor segment HIPAA compliance tool[34:22] Episode wrap up and teaser for part two[35:40] Healthtech haiku and sign-offResources:Tech It To The Limit PodcastWebsite Apple PodcastDr. Lynne NowakLinkedIn -https://www.linkedin.com/in/lynnee-nowak-md-62054583/Surescripts - https://surescripts.com/John BeadleLinkedIn - https://www.linkedin.com/in/johnpbeadle/Aegis Ventures - https://aegisventures.com/Sarah HarperLinkedIn -https://www.linkedin.com/in/sarahbethharperElliott WilsonLinkedIn - https://www.linkedin.com/in/matthewelliottwilson

In this session Sofya shares her journey building a pet-tech startup that blends machine learning sensor data and canine behavior analytics. She walks through her path from early programming explorations to launching a health monitoring device designed around anomaly detection and long-term behavioral baselines.TIMECODES: 00:00 Sofya's pet tech startup with machine learning sensor data and behavior pattern analytics10:00 Journey from programming hobby to full time software development career17:20 Career growth after skipping university and building practical experience24:07 Puppy adoption story and family influence on pet focused innovation32:16 Dog health monitoring framed as anomaly detection in real world machine learning37:05 Collecting canine data with emphasis on sleep patterns and cycle tracking43:35 Establishing a dogs normal baseline through long term data observation49:34 Startup funding through personal savings and early stage bootstrapping55:28 Finding cofounders and collaborators through meetups and coworking communities59:48 Closing insights on Sofya's educational path and early device prototypesConnect with Sofya- Website - https://www.fit-tails.com/ - Linkedin - https://www.linkedin.com/in/sofya-yulpatova/Connect with DataTalks.Club:- Join the community - https://datatalks.club/slack.html- Subscribe to our Google calendar to have all our events in your calendar - https://calendar.google.com/calendar/r?cid=ZjhxaWRqbnEwamhzY3A4ODA5azFlZ2hzNjBAZ3JvdXAuY2FsZW5kYXIuZ29vZ2xlLmNvbQ- Check other upcoming events - https://lu.ma/dtc-events- GitHub: https://github.com/DataTalksClub- LinkedIn - https://www.linkedin.com/company/datatalks-club/ - Twitter - https://twitter.com/DataTalksClub - Website - https://datatalks.club/

HSBC Innovations is the global bank's financing arm for American and European startups, especially in the healthcare and life sciences industries. The bank's semi-annual Venture Healthcare Reports document trends in the investment market.Key Tech's Andy Rogers welcomes the report's author, HSBC Innovation Managing Director Jon Norris in Episode 43 of the MedTech Speed to Data podcast.Need to know·       Four core market segments — HSBC Innovation's Venture Healthcare Reports cover investments and exits in Biopharma, Dx/Tools, Med Device, and Healthtech.·       Sourcing investment data — Norris enriches Pitchbook data with additional structure and analyses, making the report more relevant to these market segments.·       Sourcing exit data — Norris supplements media and industry publications with market research and conversations with industry leaders.·       An investment data tapestry — The reports provide “an honest picture of what's going on in the market” so investors and innovators alike “can make targeted smart decisions.”The nitty-grittyAndy and Norris discuss the investment market's recent history before exploring drivers of today's investment headwinds.“2021 was a record-setting year,” Norris recalls. “Every record that could be set for deals and dollars was set across all the sectors.” Things changed in 2022 as new BioTech IPOs struggled, prompting investment reprioritizations.“VCs had done all these… frothy valuations,” Norris says. “They had to go back and look at their own portfolios and say, does this company have enough capital? How do you want to put money to work?”Investments rebounded in 2024, but not the number of deals. Investors poured money into their existing portfolios to boost their exit chances, resulting in today's nine-figure megadeals.“Basically, they're smooshing two rounds together and extending the investors coming in to support that round,” Norris says.Headwinds stiffened in 2025 as tariffs, a more litigious competitive space, and other factors amplified business uncertainty.Norris attributes this progression to the psychology of venture capital. “When you think about what makes these folks tick,” Norris explains, “they want to continue to raise new venture funds because they get paid management fees. But in order to raise their new venture funds, they have to show their investors that they've actually gotten returns.”That means reaching an acquisition or IPO. “They're very focused on getting to exit right now. That's why they're so focused on their existing portfolio. And because of that, they haven't been doing as many new investments.”New investments still happen, of course, but the criteria have changed. “While the dollars are actually up in some of these sectors, especially Med Device,” Norris says, “you're seeing that being put to work on later-stage deals because they'd rather get a shorter time to exit.”Data that made the difference:Norris' insights from the HSBC Venture Healthcare Report let him advise startups fighting today's investment headwinds.Adopt a megaround mentality. “Series B has been extremely difficult,” Norris says. “[Raising] sub two million, that's one thing. But if you're looking to raise five million, it's almost better to raise twelve.”Find investors outside the mainstream. “Traditional venture investors don't want to write small checks.” Norris sees angel groups, innovation centers, and other small investors funding these early rounds.Explore acquisition exits, but be careful. “On the device side, most of the corporates have been pretty darn active,” Norris says. However, some litigate to block emerging competition, especially in the Dx/Tools sector. Norris' recommends researching potential acquirers before taking meetings.Download the HSBC Venture Healthcare Report for Norris' complete analysis, and watch the video below for insights into the Medical Device and Dx/Tools sectors, AI's role in MedTech, and more.

Guest: Derek Baird, CEO & Co-founder, Switchboard HealthResources:Switchboard Health: https://switchboardhealth.com/Conduce Health: https://www.conducehealth.com/Connect with Derek: https://www.linkedin.com/in/debaird/Connect with Nick: https://www.linkedin.com/in/nick-crabbs-5674a233/ Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.

In this episode of Medsider Radio, we sat down with Andrew Holman, MD, CEO of Inmedix. Inmedix is commercializing CloudHRV, an FDA-cleared diagnostic that quantifies biological stress with clinical precision to guide treatment decisions in autoimmune disease and beyond.Andrew is a practicing rheumatologist in Seattle with 25 years of clinical and research experience. His discoveries linking autonomic dysfunction to autoimmune disease outcomes led to a $10 million patent sale to Boehringer Ingelheim. After a decade in retirement, he returned to found Inmedix and pioneer the field of immuno-autonomics — preparing the market for his technology years before launch.In this interview, Andrew shares how to build a category before commercializing a product, why clinical evidence creates competitive moats that money can't replicate, and how to raise capital from angel investors by understanding what they actually care about.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Andrew Holman.

Send us a textLung cancer is often discovered too late, when treatments are expensive and survival rates are low. But what if routine chest x-rays could flag cancer early…long before symptoms appear? AI is transforming everyday imaging into a powerful early detection tool, reshaping screening economics and saving lives around the world. Prashant Warier, CEO and Founder of Qure.ai, joins CareTalk to discuss how AI enables earlier diagnosis, why chest x-rays are an untapped opportunity for detection, and what it takes to integrate AI into national health systems at scale.

Episode 69 - Dr Taz Aldawoud is a GP, NHS Innovation Accelerator Fellow and founding CEO of Doc Abode, a nationally recognised digital health company enabling the NHS to deliver faster, safer care closer to home. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Fewer, better things—that's my midlife mantra after the crazy-hard empty-nest downsizing. Smart, curated gifting feels right as we balance editing our lives and treating our loved ones as we head into 2026. London-based wellness editor Annie Goodman joins us fresh from trying "millions of face creams" to share her expertly vetted holiday guide. After her mother's health crisis sparked a holistic wellness transformation, Annie now curates for The Quality Edit. Discover results-driven skincare, health tech and LED masks, experiential gifts requiring zero wrap, and solo travel retreats. Plus, stocking stuffers galore! She's done the research—you get the perfect gift, beauties! FOLLOW A CERTAIN AGE ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ GET INBOX INSPO: Sign up for our newsletter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠AGE BOLDLY⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We share new episodes, giveaways, links we love, and midlife resources Learn more about your ad choices. Visit megaphone.fm/adchoices

Building a Brand in Healthcare's Most Competitive AI Market On this episode host Adam Turinas discusses with friend and healthtech marketing leader, Lea Chatham, what it takes to create and build a strong brand. They discuss what it really takes to build a brand in the white-hot ambient AI/clinical scribe space. They start with the reality that large buying groups are overwhelmed with noise, and increasingly turn to a few trusted sources to quietly shortlist the top two or three vendors before they ever talk to sales. If you're not consistently showing up with credibility in those channels, you may never even make the long list, let alone the shortlist. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Medsider Radio, we sat down with Colby Holtshouse, President and CEO of May Health.May Health is developing a minimally invasive ovarian ablation therapy designed to restore ovulation in women with polycystic ovary syndrome (PCOS) and PCOS-related infertility.Before May Health, Colby served as Global Medtech Commercial Lead at Organon, overseeing the worldwide launch of the Jada System following Organon's acquisition of Alydia Health, where she held roles including COO, Interim CEO, and VP of Marketing. She has also held leadership positions at Pelvalon, AccessClosure, Medtronic, and Guidant.In this discussion, Colby shares why early clinical evidence should be built in focused layers rather than oversized, all-at-once trials. She explains how a small, deliberate early launch can reveal the workflow nuances and real-world expectations no study ever captures. And she outlines why founders should define the raise first — and how clarity, preparation, and a deep understanding of strategic partners can dramatically accelerate the fundraising process.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Colby Holtshouse.

Send us a textPhone lines are jammed. Staff are overwhelmed. Patients wait, hang up, or fall through the cracks entirely. Meanwhile, the pressure to improve access keeps climbing.In this Executive Feature, Chetan Reddy, Founder and CEO of Confido Health,  joins host, David E. Williams to discuss why patient access is breaking down, how AI voice agents can resolve routine calls instantly, and what it takes for practices to improve patient experience without adding staff.

Nicole Rodrigues is the CEO and Founder of NRPR Group, the Beverly Bills public relations and marketing machine serving game changing companies from entertainment to tech around the world. NRPR focuses on building relationships that build long-lasting ties between clients, the media and their audiences. From startups to Fortune 500 companies within consumer tech, FinTech, HealthTech, enterprise, mobile, digital entertainment, lifestyle, sports, and consumer products, NRPR prides itself on a high-touch, results-focused approach to boost their clients' bottom line.

Episode 68 - Lord (James) Bethell is an entrepreneur, ex-health minister and public-health advocate with 20 years' experience across government, media and industry, including The Sunday Times, US Senate and EU Commission. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

This Episode is sponsored by Figs - for professional, clean and functional scrubs, use FIGSUK for 15% off your first order

AI Quick Take - AEO vs SEO On this episode host Adam Turinas discusses if Answer Engine Optimization (AEO) is really just SEO with a fresh coat of paint, or are we looking at something fundamentally different? This question has been nagging at him for weeks, and in this AI Quick Take he tries to answer it. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Send us a textIn Episode 12 of the Digital and Dirt podcast, Ian sits down with Melissa Gordon-Ring, Global President of Health at IPG Mediabrands, to discuss the importance of trust and human connection within the evolving health landscape. Melissa shares her perspective on leadership and the future of health communications, offering insights from her professional and personal experiences.Podcast Breakdown00:00–05:51 Introduction, Personal Insights & Role of Family05:52–11:00 Career Journey & Passion for Healthcare11:01–18:59 Navigating Consumers & Understanding IPG Mediabrands19:00–23:24 Adapting to Change & Building Trust23:25–29:06 Simplifying Healthcare Communication & Innovation29:07–32:08 Embracing Change in Media & Health Tech32:09–End The Future of Health Tech & Empowering Teams

Building Resilience in Healthcare Marketing On this episode host Adam Turinas discusses, with Mark Erwich, Health Launchpad Chief Strategy Officer, the mounting pressures on hospitals and IDNs, from shrinking margins and labor shortages to an onslaught of regulatory changes, including OPBBA, Medicaid work requirements, and ACA cuts. Mark is a healthcare technology marketing veteran with over 20 years in the industry. Mark and I discuss "the perfect storm" facing healthcare providers, and why traditional growth-focused messaging is no longer resonating with buyers. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

AI Model Mania – Navigating the Healthtech Marketers Landscape with Adam Turinas On this lively episode, host Carol Flagg welcomes back Adam Turinas, founder of Health Launchpad and host of The Healthtech Marketing Show. Adam shares the story behind his AI Quick Takes segment—particularly the episode Model Mania: Navigating the New AI Landscape, which likens today's race among AI leaders to the 1990s browser wars. He explains how major players like OpenAI, Google, Anthropic, and Meta are locked in a fierce market “land grab” and discusses how marketers can navigate this expanding AI ecosystem and prepare for the next wave—the emerging “AI browser war” fueled by tools like ChatGPT Atlas and Perplexity Comet. The episode concludes with Adam talking about his firm's new initiative, the HLP BrAIn, a centralized repository of expertise and insights into healthcare buyers. Learn more about this initiative at: https://healthlaunchpad.com/the-hlp-brain-and-more/ To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Join host Lisa as she chats with Dr. Elizabeth Harris from Brain Health and Biofeedback about her journey from traditional medicine to holistic brain health. Discover links between dental health and wellness, treatments like plasmalogens and CO2 optimisation, and advanced tech such as CVAC and NeuroField. Perfect for those battling post-concussion syndrome, long COVID, POTS, Thyroid, Gut problems or chronic health issues, plus plans for New Zealand clinics! Connect with Dr. Harris: Website: Brain Health and Biofeedback For more episodes like this one with Dr. Harris's check out these episodes: Dr. Mark Gordon - Hormones, Brain Injuries, And Neuroinflammation Dr. Dale Bredesen - How to Prevent and Reverse Alzheimers & Neurodegeneration